Compare ConocoPhillips (COP) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ConocoPhillips vs DENTSPLY SIRONA Inc — how do they compare? ConocoPhillips trades at $133.15 (market cap $161.21B), while DENTSPLY SIRONA Inc trades at $8.78 (market cap $1.73B). The key difference: ConocoPhillips is far larger — about 93.2× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold ConocoPhillips for 79 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| COP | XRAY | |
|---|---|---|
Market Cap | $161.21B | $1.73B |
Volume | 6,058,403 | 6,198,582 |
Sector | Energy | Health |
52-Week High | $141.22 | $14.68 |
52-Week Low | $85.66 | $8.52 |
Typical Hold Time | 79 Days | 72 Days |
Enterprise Value | $176.81B | $3.80B |
Dividend Yield | 2.5% | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ConocoPhillips (COP) trades at $129.84, up 0.38% today, with strong technical momentum and bullish moving average signals. The company reported mixed Q4 2025 earnings but beat expectations in Q1 and Q2 2026, with revenue growth from $58.94B in 2025 to projected $63.3B in 2026. Recent developments include a 20-year LNG supply agreement with Venture Global and potential asset sales in Norway and the UK, signaling strategic portfolio optimization.
COP presents a compelling investment case with solid fundamentals—P/E of 17.75, ROE of 14.14%, and robust cash flow—supported by a 75% analyst buy rating and $154.75 consensus price target. Key risks include geopolitical exposure in the Middle East, oil price volatility, and execution of asset sales. The stock's current level near resistance at $130 suggests near-term consolidation potential amid bullish long-term prospects.
DENTSPLY SIRONA (XRAY) trades at $8.54, near a 52-week low, with a bearish technical signal from moving averages. The company reported a Q2 2026 earnings beat but faces declining revenues and negative net income margins. Recent news highlights institutional stake increases and ongoing turnaround efforts amid sales weakness in dental segments.
The outlook remains challenging due to persistent profitability issues and high debt, though analyst consensus suggests upside to a $13.40 price target. Key risks include margin pressure and competitive threats, while potential catalysts include successful restructuring and digital dentistry growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ConocoPhillips
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
